spacer
spacer
Go to PDB code: 
protein ligands metals Protein-protein interface(s) links
Oxidoreductase PDB id
1lrt
Jmol
Contents
Protein chains
338 a.a. *
Ligands
BOG ×2
IMP ×4
TAD ×4
TRS ×12
Metals
__K ×4
Waters ×543
* Residue conservation analysis
PDB id:
1lrt
Name: Oxidoreductase
Title: Crystal structure of ternary complex of tritrichomonas foetus inosine-5'-monophosphate dehydrogenase: structural characterization of NAD+ site in microbial enzyme
Structure: Inosine-5'-monophosphate dehydrogenase. Chain: a, b, c, d. Synonym: inosine-5'-monophosphate dehydrogenase, imp dehydrogenase, impdh, impd. Engineered: yes
Source: Tritrichomonas foetus. Organism_taxid: 5724. Gene: impdh. Expressed in: escherichia coli. Expression_system_taxid: 562.
Biol. unit: Tetramer (from PQS)
Resolution:
2.20Å     R-factor:   0.212     R-free:   0.246
Authors: L.Gan,G.A.Petsko,L.Hedstrom
Key ref:
L.Gan et al. (2002). Crystal structure of a ternary complex of Tritrichomonas foetus inosine 5'-monophosphate dehydrogenase: NAD+ orients the active site loop for catalysis. Biochemistry, 41, 13309-13317. PubMed id: 12403633 DOI: 10.1021/bi0203785
Date:
15-May-02     Release date:   07-Jul-03    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P50097  (IMDH_TRIFO) -  Inosine-5'-monophosphate dehydrogenase
Seq:
Struc:
503 a.a.
338 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 1 residue position (black cross)

 Enzyme reactions 
   Enzyme class: E.C.1.1.1.205  - Imp dehydrogenase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]

      Pathway:
AMP and GMP Biosynthesis
      Reaction: Inosine 5'-phosphate + NAD+ + H2O = xanthosine 5'-phosphate + NADH
Inosine 5'-phosphate
Bound ligand (Het Group name = IMP)
corresponds exactly
+ NAD(+)
+ H(2)O
= xanthosine 5'-phosphate
+ NADH
Molecule diagrams generated from .mol files obtained from the KEGG ftp site
 Gene Ontology (GO) functional annotation 
  GO annot!
  Biological process     metabolic process   2 terms 
  Biochemical function     catalytic activity     2 terms  

 

 
    reference    
 
 
DOI no: 10.1021/bi0203785 Biochemistry 41:13309-13317 (2002)
PubMed id: 12403633  
 
 
Crystal structure of a ternary complex of Tritrichomonas foetus inosine 5'-monophosphate dehydrogenase: NAD+ orients the active site loop for catalysis.
L.Gan, G.A.Petsko, L.Hedstrom.
 
  ABSTRACT  
 
Inosine 5'-monophosphate dehydrogenase (IMPDH) catalyzes the conversion of IMP to XMP with the reduction of NAD(+), which is the rate-limiting step in the biosynthesis of guanine nucleotides. IMPDH is a promising target for chemotherapy. Microbial IMPDHs differ from mammalian enzymes in their lower affinity for inhibitors such as mycophenolic acid (MPA) and thiazole-4-carboxamide adenine dinucleotide (TAD). Part of this resistance is determined by the coupling between nicotinamide and adenosine subsites in the NAD(+) binding site that is postulated to involve an active site flap. To understand the structural basis of the drug selectivity, we solved the X-ray crystal structure of the catalytic core domain of Tritrichomonas foetus IMPDH in complex with IMP and beta-methylene-TAD at 2.2 A resolution. Unlike previous structures of this enzyme, the active site loop is ordered in this complex, and the catalytic Cys319 is 3.6 A from IMP, in the same plane as the hypoxanthine ring. The active site loop forms hydrogen bonds to the carboxamide of beta-Me-TAD which suggests that NAD(+) promotes the nucleophillic attack of Cys319 on IMP. The interactions of the adenosine end of TAD are very different from those in the human enzyme, suggesting the NAD(+) site may be an exploitable target for the design of antimicrobial drugs. In addition, a new K(+) site is observed at the subunit interface. This site is adjacent to beta-Me-TAD, consistent with the link between the K(+) activation and NAD(+). However, contrary to the coupling model, the flap does not cover the adenosine subsite and remains largely disordered.
 

Literature references that cite this PDB file's key reference

  PubMed id Reference
21035731 D.R.Gollapalli, I.S.Macpherson, G.Liechti, S.K.Gorla, J.B.Goldberg, and L.Hedstrom (2010).
Structural determinants of inhibitor selectivity in prokaryotic IMP dehydrogenases.
  Chem Biol, 17, 1084-1091.  
19480389 L.Hedstrom (2009).
IMP dehydrogenase: structure, mechanism, and inhibition.
  Chem Rev, 109, 2903-2928.  
19153081 M.Pimkin, J.Pimkina, and G.D.Markham (2009).
A Regulatory Role of the Bateman Domain of IMP Dehydrogenase in Adenylate Nucleotide Biosynthesis.
  J Biol Chem, 284, 7960-7969.  
19919089 S.Das, A.Kokardekar, and C.M.Breneman (2009).
Rapid comparison of protein binding site surfaces with property encoded shape distributions.
  J Chem Inf Model, 49, 2863-2872.  
18295591 D.Xu, G.Cobb, C.J.Spellicy, S.J.Bowne, S.P.Daiger, and L.Hedstrom (2008).
Retinal isoforms of inosine 5'-monophosphate dehydrogenase type 1 are poor nucleic acid binding proteins.
  Arch Biochem Biophys, 472, 100-104.  
18312263 M.Pimkin, and G.D.Markham (2008).
The CBS subdomain of inosine 5'-monophosphate dehydrogenase regulates purine nucleotide turnover.
  Mol Microbiol, 68, 342-359.  
17480004 Q.Shu, and V.Nair (2008).
Inosine monophosphate dehydrogenase (IMPDH) as a target in drug discovery.
  Med Res Rev, 28, 219-232.  
18974094 S.E.Mortimer, D.Xu, D.McGrew, N.Hamaguchi, H.C.Lim, S.J.Bowne, S.P.Daiger, and L.Hedstrom (2008).
IMP dehydrogenase type 1 associates with polyribosomes translating rhodopsin mRNA.
  J Biol Chem, 283, 36354-36360.  
18642884 T.V.Riera, W.Wang, H.R.Josephine, and L.Hedstrom (2008).
A kinetic alignment of orthologous inosine-5'-monophosphate dehydrogenases.
  Biochemistry, 47, 8689-8696.  
17128977 B.OuYang, S.S.Pochapsky, G.M.Pagani, and T.C.Pochapsky (2006).
Specific effects of potassium ion binding on wild-type and L358P cytochrome P450cam.
  Biochemistry, 45, 14379-14388.  
16267046 E.Di Cera (2006).
A structural perspective on enzymes activated by monovalent cations.
  J Biol Chem, 281, 1305-1308.  
15917510 W.J.Sullivan, S.E.Dixon, C.Li, B.Striepen, and S.F.Queener (2005).
IMP dehydrogenase from the protozoan parasite Toxoplasma gondii.
  Antimicrob Agents Chemother, 49, 2172-2179.  
15269207 N.N.Umejiego, C.Li, T.Riera, L.Hedstrom, and B.Striepen (2004).
Cryptosporidium parvum IMP dehydrogenase: identification of functional, structural, and dynamic properties that can be exploited for drug design.
  J Biol Chem, 279, 40320-40327.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time.